Showing 1 - 2 results of 2 for search 'Bert Vanmechelen', query time: 0.01s Refine Results
  1. 1
    A retrospective genomic characterisation of the 2022 mpox outbreak in Belgium, and in vitro assessment of three antiviral compoundsResearch in context

    A retrospective genomic characterisation of the 2022 mpox outbreak in Belgium, and in vitro assessment of three antiviral compoundsResearch in context by Tony Wawina-Bokalanga, Bert Vanmechelen, Anne-Sophie Logist, Mandy Bloemen, Lies Laenen, Sébastien Bontems, Marie-Pierre Hayette, Cécile Meex, Christelle Meuris, Catherine Orban, Emmanuel André, Robert Snoeck, Guy Baele, Samuel L. Hong, Graciela Andrei, Piet Maes

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    A guanidine-based coronavirus replication inhibitor which targets the nsp15 endoribonuclease and selects for interferon-susceptible mutant viruses.

    A guanidine-based coronavirus replication inhibitor which targets the nsp15 endoribonuclease and selects for interferon-susceptible mutant viruses. by Benjamin Van Loy, Eugènia Pujol, Kenichi Kamata, Xiao Yin Lee, Nikolai Bakirtzoglou, Ria Van Berwaer, Julie Vandeput, Cato Mestdagh, Leentje Persoons, Brent De Wijngaert, Quinten Goovaerts, Sam Noppen, Maarten Jacquemyn, Kourosh Ahmadzadeh, Eline Bernaerts, Juan Martín-López, Celia Escriche, Bert Vanmechelen, Besir Krasniqi, Abhimanyu K Singh, Dirk Daelemans, Piet Maes, Patrick Matthys, Wim Dehaen, Jef Rozenski, Kalyan Das, Arnout Voet, Santiago Vázquez, Lieve Naesens, Annelies Stevaert

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: